Why Do Large B-Cell Lymphoma Patients With High Tumor Mutation Burden Relapse on CAR T-Cell Therapy?
Researchers explored this question at ASH and shared data suggesting genomic instability in tumors with high TMB likely enables them to hide from immune attack.
Company expects continued dividend payments and evaluates expansion beyond 5,500 tpd supported by largest-ever drill programVANCOUVER, BC, Dec. 8, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback